kabutan

RIKEN TECHNOS CORPORATION(4220) Summary

4220
TSE Prime
RIKEN TECHNOS CORPORATION
1,431
JPY
-12
(-0.83%)
Dec 5, 3:00 pm JST
9.25
USD
Dec 5, 1:00 am EST
Result
PTS
outside of trading hours
1,430.8
Dec 5, 3:00 pm JST
Summary Chart Historical News Financial Result
PER
10.4
PBR
1.07
Yield
3.28%
Margin Trading Ratio
3.22
Stock Price
Dec 5, 2025
Opening Dec 5, 9:00 am
1,422 JPY 9.16 USD
Previous Close Dec 4
1,443 JPY 9.28 USD
High Dec 5, 1:03 pm
1,441 JPY 9.29 USD
Low Dec 5, 9:00 am
1,422 JPY 9.16 USD
Volume
46,300
Trading Value
0.07B JPY 0.43M USD
VWAP
1430.05 JPY 9.25 USD
Minimum Trading Value
143,100 JPY 925 USD
Market Cap
0.07T JPY 0.48B USD
Number of Trades
262
Liquidity & Number of Trades
As of Dec 5, 2025
Liquidity
Mid
1-Year Average
292
1-Year High Oct 31, 2025
1,559
Margin Trading
Date Short Interest Long Margin Positions Ratio
Nov 28, 2025 23,100 47,200 2.04
Nov 21, 2025 21,700 46,600 2.15
Nov 14, 2025 21,100 58,100 2.75
Nov 7, 2025 23,000 61,600 2.68
Oct 31, 2025 24,200 58,600 2.42
Company Profile
RIKEN TECHNOS CORPORATION is a leading manufacturer of PVC compounds. The company also has a strong presence in decorative films, with its highly transparent films featuring antibacterial properties.
Sector
Chemicals
RIKEN TECHNOS CORPORATION specializes in synthetic resin processing, manufacturing and selling compounds, films, and food packaging materials. The company's operations are divided into four market-based segments, covering Transportation (including automotive, railway, and marine), Daily Life & Healthcare, Electronics, and Building & Construction. RIKEN TECHNOS CORPORATION provides products for a wide range of industries, including functional parts for automobiles, medical and healthcare products, cable materials for information infrastructure, and construction materials. With numerous subsidiaries both domestically and internationally, the company operates on a global scale. RIKEN TECHNOS CORPORATION is particularly focused on establishing a strong presence in the Asian and North American automotive markets, while also concentrating on expanding its high-value-added products in the medical field.